Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Trypanosomiasis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Trypanosomiasis to Infectious Disease Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Trypanosomiasis Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 169
Abbreviations 169
Definitions 169
Research Methodology 170
Secondary Research 170
About GlobalData 170
Contact Us 171
Source 171

List of Tables
Trypanosomiasis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Trypanosomiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Trypanosomiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Trypanosomiasis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Trypanosomiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Trypanosomiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

List of Figures
Trypanosomiasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Trypanosomiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Trypanosomiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Trypanosomiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Trypanosomiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Trypanosomiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 20
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Trypanosomiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Trypanosomiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 170

Companies Mentioned
- Medecins Sans Frontieres
- Sanofi
- International Centre for Diarrhoeal Disease Research Bangladesh
- Bayer AG
- Knight Therapeutics Inc
- SGS North America Inc
- Lifecare Innovations Pvt Ltd
- Insud Pharma
- Immtech Pharmaceuticals Inc
- Aeterna Zentaris Inc